Systematic review and Meta-analysis of 26 randomized controlled clinical trials of Compound Danshen Dripping Pill for non-proliferating diabetic retinopathy.

Wang, Yu; Hao, Lei; Huo, Zhipeng; Liu, Yuanxue; Sun, Yujing; Song, Zhaohui

Wang, Yu; Hao, Lei; Huo, Zhipeng; Liu, Yuanxue; Sun, Yujing; Song, Zhaohui.

Afiliación

Wang Y; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Academy, Tasly Holding Group Co., Ltd., Tianjin 300410, China.
Hao L; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Academy, Tasly Holding Group Co., Ltd., Tianjin 300410, China.
Huo Z; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Academy, Tasly Holding Group Co., Ltd., Tianjin 300410, China.
Liu Y; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Academy, Tasly Holding Group Co., Ltd., Tianjin 300410, China.
Sun Y; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Academy, Tasly Holding Group Co., Ltd., Tianjin 300410, China.
Song Z; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Academy, Tasly Holding Group Co., Ltd., Tianjin 300410, China.

Chin Herb Med ; 14(1): 142-153, 2022 Jan.

Article en En | MEDLINE | ID: mdl-36120120

Palabras clave

Compound Danshen Dripping Pill; Meta-analysis; diabetic retinopathy; randomized controlled clinical trial; systemic review

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Tipo de estudio: Clinical_trials / Guideline / Systematic_reviews Idioma: En Revista: Chin Herb Med Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google